GRAND RAPIDS, MI -- (MARKET WIRE) -- March 19, 2007 -- Oncologix Tech Inc.'s (OTCBB: OCLG) wholly owned subsidiary, Oncologix Corporation, announced today that the Institut de Cardiologie de Montréal (Montreal Heart Institute) and Dr. Raoul Bonan have agreed to provide the facilities, equipment, and expertise necessary to assist Oncologix in performing animal research studies with its Oncosphere System. The studies are required to be completed as part of the data submitted to the Food and Drug Administration (FDA) to support a request for initiation of human clinical research.
